Published in Int J Pharm on November 17, 2007
A recombinant polypeptide extends the in vivo half-life of peptides and proteins in a tunable manner. Nat Biotechnol (2009) 1.77
Target-mediated pharmacokinetic and pharmacodynamic model of exendin-4 in rats, monkeys, and humans. Drug Metab Dispos (2012) 1.00
Dose combinations of exendin-4 and salmon calcitonin produce additive and synergistic reductions in food intake in nonhuman primates. Am J Physiol Regul Integr Comp Physiol (2010) 0.94
Interspecies modeling and prediction of human exenatide pharmacokinetics. Pharm Res (2012) 0.89
Effects of Exendin-4 on human adipose tissue inflammation and ECM remodelling. Nutr Diabetes (2016) 0.76
Nanoplex delivery of siRNA and prodrug enzyme for multimodality image-guided molecular pathway targeted cancer therapy. ACS Nano (2010) 1.01
Exploiting the tumor microenvironment for theranostic imaging. NMR Biomed (2011) 0.85
Tumor endothelium marker-8 based decoys exhibit superiority over capillary morphogenesis protein-2 based decoys as anthrax toxin inhibitors. PLoS One (2011) 0.83
Prodrug enzymes and their applications in image-guided therapy of cancer: tracking prodrug enzymes to minimize collateral damage. Drug Deliv Transl Res (2012) 0.81
Validation of a sensitive gas chromatographic-mass spectrometric method for the simultaneous determination of beta-elemene and beta-elemenal in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci (2008) 0.79
Quantitative analysis of a novel HIV fusion inhibitor (sifuvirtide) in HIV infected human plasma using high-performance liquid chromatography-electrospray ionization tandem mass spectrometry. J Pharm Biomed Anal (2009) 0.78
The extract of inflamed rabbit skin induced by inoculation of vaccinia virus possesses antioxidant and neuroprotective effects in acute ischemic stroke. J Stroke Cerebrovasc Dis (2009) 0.78
A new approach for pharmacokinetics of single-dose cetuximab in rhesus monkeys by surface plasmon resonance biosensor. J Pharm Biomed Anal (2009) 0.78
MRI of metastasis-permissive microenvironments. Future Oncol (2011) 0.78
Pharmacokinetics of sifuvirtide in treatment-naive and treatment-experienced HIV-infected patients. J Pharm Sci (2014) 0.77
Magnetic Resonance Imaging and Spectroscopy in Cancer Theranostic Imaging. Top Magn Reson Imaging (2016) 0.76
Theranostic imaging of cancer. Eur J Radiol (2012) 0.75
Development of a rapid and sensitive LC-MS/MS assay for the determination of combretastatin A4 phosphate, combretastatin A4 and combretastatin A4 glucuronide in beagle dog plasma and its application to a pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci (2009) 0.75
The induction of prolonged myelopoietic effects in monkeys by GW003, a recombinant human granulocyte colony-stimulating factor genetically fused to recombinant human albumin. J Pharm Sci (2014) 0.75
An LC-MS/MS assay to determine plasma pharmacokinetics of cyclic thymic hexapeptide (cTP6) in rhesus monkeys. J Chromatogr B Analyt Technol Biomed Life Sci (2011) 0.75
Targeted LC-MS quantification of intact TAT-fusion therapeutics: a case study. Bioanalysis (2015) 0.75
Qualitative and quantitative studies on human B7.1-Fc fusion protein and the application in pharmacokinetic study in rhesus monkeys. J Pharm Biomed Anal (2010) 0.75
Validation of a sensitive LC/MS/MS method for simultaneous quantitation of flupentixol and melitracene in human plasma. J Pharm Biomed Anal (2007) 0.75